Carregant...
Low dose rapamycin exacerbates autoimmune experimental uveitis.
Rapamycin, a potent immune modulator, is used to treat transplant rejection and some autoimmune diseases. Uveitis is a potentially severe inflammatory eye disease, and 2 clinical trials of treating uveitis with rapamycin are under way. Unexpectedly, recent research has demonstrated that low dose rap...
Guardat en:
Autors principals: | , , , , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Public Library of Science (PLoS)
2012-01-01
|
Col·lecció: | PLoS ONE |
Accés en línia: | http://europepmc.org/articles/PMC3344911?pdf=render |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|